M. Hale

The long and the short of it: insights into the cellular source of autoantibodies as revealed by B cell depletion therapy.

D. Rawlings, S. Jackson, M. Hale, 2018, Current opinion in immunology.

Efficient Modification of the CCR5 Locus in Primary Human T Cells With megaTAL Nuclease Establishes HIV-1 Resistance

B. Stoddard, D. Rawlings, H. Kiem, 2016, Molecular therapy. Nucleic acids.

Efficient Modification of the CCR5 Locus in Primary Human T Cells With megaTAL Nuclease Establishes HIV-1 Resistance

B. Stoddard, D. Rawlings, H. Kiem, 2016, Molecular therapy. Nucleic acids.

Homology-Directed Recombination for Enhanced Engineering of Chimeric Antigen Receptor T Cells

A. Scharenberg, D. Rawlings, S. Jackson, 2017, Molecular therapy. Methods & clinical development.

IgM antibodies derived from memory B cells are potent cross-variant neutralizers of SARS-CoV-2

Linhui Hao, N. King, Michael J Watson, 2022, The Journal of experimental medicine.

Dynamics of SARS-CoV-2 VOC neutralization and novel mAb reveal protection against Omicron

P. Drain, R. Baric, A. Sigal, 2022, medRxiv.

Effective, safe, and sustained correction of murine XLA using a UCOE-BTK promoter-based lentiviral vector

B. Ryu, D. Rawlings, Joseph Pangallo, 2021, Molecular therapy. Methods & clinical development.